
Opinion|Videos|April 30, 2024
Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization
Mahsa Salsabili, PharmD, PhD, explores risk and value-based contracting for prescription digital therapeutics, along with strategies for manufacturers to support their utilization and optimization, while also delving into cost-effectiveness modeling and budget impact analysis.
Advertisement
Episodes in this series

Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare’s first-year payments for social needs showed high use by primary care but many claims were denied
2
House passes funding bill that includes PBM reform
3
See which Minnesota healthcare CEOs signed letter calling for 'immediate deescalation of tensions' following shooting of Alex Pretti
4
Do you know what’s in your contracts?
5



























